Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2018, Article ID 8031328, 11 pages
https://doi.org/10.1155/2018/8031328
Research Article

Fecal Galectin-3: A New Promising Biomarker for Severity and Progression of Colorectal Carcinoma

1Department of Abdominal Surgery, Military Medical Academy, Belgrade, Serbia
2Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
3Department of Internal Medicine, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
4Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
5Institute for Medical Research, Military Medical Academy, Belgrade, Serbia
6Department of Surgery, Faculty of Medicine Foca, University of East Sarajevo, Sarajevo, Bosnia and Herzegovina

Correspondence should be addressed to Nevena Gajovic; moc.oohay@anevencivojag

Received 29 December 2017; Revised 26 February 2018; Accepted 5 March 2018; Published 4 April 2018

Academic Editor: Amedeo Amedei

Copyright © 2018 Milan Jovanovic et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Milan Jovanovic, Nevena Gajovic, Natasa Zdravkovic, et al., “Fecal Galectin-3: A New Promising Biomarker for Severity and Progression of Colorectal Carcinoma,” Mediators of Inflammation, vol. 2018, Article ID 8031328, 11 pages, 2018. https://doi.org/10.1155/2018/8031328.